Type and hit ENTER

Footer – After

Shout WordPress Theme by Pirenko.

Made in Portugal. With Love.

ProAxsis accelerates work on inflammatory biomarkers associated with COVID-19

August 3, 2020
ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been …
ProAxsis investing in R&D to create new diagnostic tests for chronic human diseases

July 27, 2020
Belfast based respiratory diagnostics company, ProAxsis is investing over £200,000 in R&D to …
ProAxsis and the Connected Health Innovation Centre launch new partnership

July 9, 2020
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting …

ProAxsis

RT @ProfJDChalmers: Great to see neutrophil elastase and biomarker guided endotypes centre stage in the future of bronchiectasis management…

9 days ago

RT @ProfJDChalmers: We are delighted to publish the final results of the WILLOW trial of DPP1 inhibition in bronchiectasis in the @NEJM - t…

14 days ago

RT @ProfJDChalmers: We have known for many years that neutrophils are central to the pathophysiology of bronchiectasis, and neutrophil elas…

14 days ago

RT @InvestNI: Great news today for @QUB who has been granted significant funding from @UKRI_News Strength in Places Fund #innovation >> htt…

41 days ago

Footer - After | ProAxsis